3939-34-2

Upstream product

• 619-66-9 4-Carboxybenzaldehyde 
• 62-53-3 aniline 
• 98-95-3 nitrobenzene 
• 623-27-8 terephthalaldehyde, 

Downstream Products

• 110137-64-9 4-((phenylamino)methyl)benzoic acid 
• 538-51-2 benzylidene phenylamine 

Relevant academic research and scientific papers

Novel steroid derivatives: synthesis, antileishmanial activity, mechanism of action, and in silico physicochemical and pharmacokinetics studies

The search for new drugs for the treatment of leishmaniasis is an important strategy for improving the current therapeutic arsenal for the disease. There are several limitations to the available drugs including high toxicity, low efficacy, prolonged paren

Highly chemoselective synthesis of imine over Co/Zn bimetallic MOFs derived Co3ZnC-ZnO embed in carbon nanosheet catalyst

One-pot direct synthesis of imines via reductive amination of nitroarenes with aromatic aldehydes remains a great challenge due in part to its over-hydrogenation of imines to secondary amines. Herein, a novel Co3ZnC and ZnO supported on N-doped carbon nanosheet catalyst with the thickness of ca. 5.0 nm was fabricated through the direct pyrolysis of a Co/Zn bimetallic MOFs at 500 °C (named as Co3ZnC-ZnO/NC-500). Surprisingly, the developed Co3ZnC-ZnO/NC-500 catalyst delivers 99.9 % conversion of nitrobenzene and 98.5 % selectivity to N-benzylideneaniline in one-pot reductive amination of nitrobenzene with benzaldehyde. Various characterizations (including as SEM, XRD, TEM, AFM, XPS, Raman and N2 adsorption–desorption) have revealed that the generated small size of Co3ZnC alloy, abundant structural defects, larger specific surface area (105.5 m2·g?1) as well as more basic sites are responsible for the outstanding catalytic activity of Co3ZnC-ZnO/NC-500 catalyst for tandem reaction. Moreover, the Co3ZnC-ZnO/NC-500 catalyst exhibits high stability during the recycling experiments without the loss of its catalytic activity. Notably, the results of contrast experiments have demonstrated that the intentional introduction of ZnO in Co3ZnC-ZnO/NC-500 catalyst plays a key role in the selectivity to N-benzylideneaniline in the tandem reaction. This study provides a new guideline for designing tandem catalysts with high selectivity.

The effect of hydrogen bonding and azomethine group orientation on liquid crystal properties in benzylidene aniline compounds

This study examines the effects of substituents and hydrogen bonding, orientations of imine linkage on the behavior of benzylidene aniline compounds as liquid crystals (LC). Compounds 4-carboxy benzylidene-4-X-aniline (X = H, F, Cl, Br, CH3, OCH3) 1a-6a were synthesized by the reaction of aniline and its substituted derivatives with 4-formylbenzoic acid. Compounds 4-X-benzylidene-4-carboxy aniline (X = H, F, Cl, Br, CH3, OCH3) 1b-6b were synthesized by the reaction of benzaldehyde and its substituted derivatives with 4-aminobenzoic acid using absolute ethanol as the solvent. Synthesized compounds were characterized by FT IR and 1H NMR spectroscopy, liquid crystal properties were investigated using differential scanning calorimetry (DSC) and polarizing optical microscopy (POM) techniques. Based on the mesomorphic properties, it was proven that the compounds 2b-4b are dimorphic exhibiting a smectic and nematic phase, compounds 5b, 6b are monomorphic exhibiting a nematic phase, while compounds 1a-6a and 1b have not shown any mesophase. For compounds 1a-6a hydrogen bonding and reversing imine linkage (in comparison with compounds 1b-6b) caused the absence of their mesomorphic properties.

In silico, in vitro and in vivo studies indicate resveratrol analogue as a potential alternative for neuroinflammatory disorders

Inflammaging is known as an imbalance between pro-inflammatory and anti-inflammatory immune mechanisms, being related to the onset of neurological disorders, such as major depression and Alzheimer's disease. Considering the known disadvantages regarding the FDA approved drug to manage such illnesses, resveratrol emerges as a natural drug candidate, despite its low bioavailability. In this study, resveratrol analogues were evaluated for their capacity of inhibiting acetylcholinesterase in silico, in vitro, and in vivo. Molecular docking simulations pointed out RSVA1 and RSVA6 as potent inhibitors, even more than resveratrol. Ellman's assay demonstrated RSVA6 as capable of inhibiting 92.4% of the enzyme activity. Further, male Swiss mice were pretreated with RSVA6 (100 mg kg?1) 60 min before receiving scopolamine (1 mg kg?1). The Novel Recognition Object (NOR), Object Location (OLT), and Buried Pellet tests (BPL) demonstrated an RSVA6 neuroprotective effect. In the second round of tests, mice received a single intraperitoneal injection of lipopolysaccharide (0.5 mg kg?1) 24 h before treatment with RSVA6 (1, 10, and 100 mg kg?1). The Open Field (OFT), Tail Suspension (TST), and Splash tests (ST) were evaluated. LPS had no significant effect on the crossing and rearing number, indicating an association between the immobility time and anhedonia observed in the TST and ST, respectively, with depressive-like behavior. RSVA6 significantly reduced the depressive-like behavior triggered by LPS in the TST and ST. Altogether, our data suggest RSVA6 as a potential drug candidate for the treatment of neuroinflammatory conditions.

Direct and indirect reductive amination of aldehydes and ketones with solid acid-activated sodium borohydride under solvent-free conditions

A simple and convenient procedure for reductive amination of aldehydes and ketones using sodium borohydride activated by boric acid, p-toluenesulfonic acid monohydrate or benzoic acid as reducing agent under solvent-free conditions is described.